Kathryn Rowan
Overview
Explore the profile of Kathryn Rowan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
11635
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lamontagne F, Masse M, Yarnell C, Camirand-Lemyre F, Levesque S, Domingue M, et al.
CMAJ
. 2024 Jun;
196(23):E779-E788.
PMID: 38885975
Background: The response of Canada's research community to the COVID-19 pandemic provides a unique opportunity to examine the country's clinical health research ecosystem. We sought to describe patterns of enrolment...
2.
Brown A, Ferrando-Vivas P, Popa M, de la Fuente G, Pappachan J, Cuthbertson B, et al.
Health Technol Assess
. 2024 Feb;
28(8):1-84.
PMID: 38421007
Background: Healthcare-associated infections are a major cause of morbidity and mortality in critically ill children. In adults, data suggest the use of selective decontamination of the digestive tract may reduce...
3.
Horby P, Peto L, Staplin N, Campbell M, Pessoa-Amorim G, Mafham M, et al.
Nat Commun
. 2024 Jan;
15(1):924.
PMID: 38296965
Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]),...
4.
Pathan N, Woolfall K, Popa M, de la Fuente G, Ferrando-Vivas P, Brown A, et al.
Sci Rep
. 2023 Dec;
13(1):21668.
PMID: 38066012
Healthcare-associated infections (HCAIs) are a major cause of morbidity and mortality in critically ill children. Data from adult studies suggest Selective Decontamination of the Digestive tract (SDD) may reduce the...
5.
Vlachos S, Rubenfeld G, Menon D, Harrison D, Rowan K, Maharaj R
Resuscitation
. 2023 Sep;
193:109956.
PMID: 37661013
Aim: Frequency and timing of Withdrawal of Life-Sustaining Treatment (WLST) after Out-of-Hospital Cardiac Arrest (OHCA) vary across Intensive Care Units (ICUs) in the United Kingdom (UK) and may be a...
6.
Esper A, Arabi Y, Cecconi M, Du B, Giamarellos-Bourboulis E, Juffermans N, et al.
Crit Care
. 2022 Nov;
26(1):366.
PMID: 36443764
Since the advent of critical care in the twentieth century, the core elements that are the foundation for critical care systems, namely to care for critically ill and injured patients...
7.
Martin D, Harrison D, Mouncey P, ODriscoll B, Grocott M, Miller L, et al.
Thorax
. 2022 Mar;
77(5):431-432.
PMID: 35301242
No abstract available.
8.
Granholm A, Alhazzani W, Derde L, Angus D, Zampieri F, Hammond N, et al.
Intensive Care Med
. 2021 Dec;
48(2):164-178.
PMID: 34853905
Randomised clinical trials (RCTs) are the gold standard for providing unbiased evidence of intervention effects. Here, we provide an overview of the history of RCTs and discuss the major challenges...
9.
Bedford J, Drikite L, Corbett M, Doidge J, Ferrando-Vivas P, Johnson A, et al.
Health Technol Assess
. 2021 Dec;
25(71):1-174.
PMID: 34847987
Background: New-onset atrial fibrillation occurs in around 10% of adults treated in an intensive care unit. New-onset atrial fibrillation may lead to cardiovascular instability and thromboembolism, and has been independently...
10.
Bedford J, Johnson A, Redfern O, Gerry S, Doidge J, Harrison D, et al.
J Crit Care
. 2021 Nov;
67:149-156.
PMID: 34798373
Background: New-onset atrial fibrillation (NOAF) is common in patients on an intensive care unit (ICU). Evidence guiding treatments is limited, though recent reports suggest beta blocker (BB) therapy is associated...